TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T09199 XX ID T09199 XX DT 08.08.2006 (created); lyn. DT 02.06.2014 (updated); yre. CO Copyright (C), QIAGEN. XX FA STAT5A-isoform1 XX SY Signal Transducer and Activator of Transcription 1; signal transducer and activator of transcription 5a; STAT5; STAT5A. XX OS human, Homo sapiens OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; primates XX GE G002606 STAT5A; HGNC: STAT5A. XX CL C0039; STAT. XX SZ 794 AA; 90.6 kDa (calc.). XX SQ MAGWIQAQQLQGDALRQMQVLYGQHFPIEVRHYLAQWIESQPWDAIDLDNPQDRAQATQL SQ LEGLVQELQKKAEHQVGEDGFLLKIKLGHYATQLQKTYDRCPLELVRCIRHILYNEQRLV SQ REANNCSSPAGILVDAMSQKHLQINQTFEELRLVTQDTENELKKLQQTQEYFIIQYQESL SQ RIQAQFAQLAQLSPQERLSRETALQQKQVSLEAWLQREAQTLQQYRVELAEKHQKTLQLL SQ RKQQTIILDDELIQWKRRQQLAGNGGPPEGSLDVLQSWCEKLAEIIWQNRQQIRRAEHLC SQ QQLPIPGPVEEMLAEVNATITDIISALVTSTFIIEKQPPQVLKTQTKFAATVRLLVGGKL SQ NVHMNPPQVKATIISEQQAKSLLKNENTRNECSGEILNNCCVMEYHQATGTLSAHFRNMS SQ LKRIKRADRRGAESVTEEKFTVLFESQFSVGSNELVFQVKTLSLPVVVIVHGSQDHNATA SQ TVLWDNAFAEPGRVPFAVPDKVLWPQLCEALNMKFKAEVQSNRGLTKENLVFLAQKLFNN SQ SSSHLEDYSGLSVSWSQFNRENLPGWNYTFWQWFDGVMEVLKKHHKPHWNDGAILGFVNK SQ QQAHDLLINKPDGTFLLRFSDSEIGGITIAWKFDSPERNLWNLKPFTTRDFSIRSLADRL SQ GDLSYLIYVFPDRPKDEVFSKYYTPVLAKAVDGYVKPQIKQVVPEFVNASADAGGSSATY SQ MDQAPSPAVCPQAPYNMYPQNPDHVLDQDGEFDLDETMDVARHVEELLRRPMDSLDSRLS SQ PPAGLFTSARGSLS XX SC translated from EMBL #L41142 XX FT 2 126 PF02865; STAT protein, protein interaction domain. FT 138 330 PF01017; STAT protein, all-alpha domain. FT 146 481 PF00478; IMP dehydrogenase / GMP reductase domain. FT 332 583 PF02864; STAT protein, DNA binding domain. FT 587 700 SM00252; SH2_5. FT 589 670 PF00017; SH2 domain. FT 589 686 PS50001; SH2. XX IN T34682 Hp1-alpha; human, Homo sapiens. XX MX M00457 V$STAT5A_01. MX M00460 V$STAT5A_02. MX M00493 V$STAT5A_03. MX M00499 V$STAT5A_04. MX M07311 V$STAT5A_Q4. MX M01890 V$STAT5A_Q6. MX M00223 V$STAT_01. MX M00777 V$STAT_Q6. XX BS R10477. BS R10478. BS R10479. BS R10480. BS R10481. BS R10482. BS R10483. BS R10484. BS R10485. BS R10486. BS R11962. BS R11963. BS R11964. BS R11965. BS R11966. BS R11967. BS R11968. BS R11969. BS R11970. BS R11971. BS R10487. BS R10488. BS R10489. BS R10490. BS R10491. BS R10492. BS R10493. BS R10494. BS R10495. BS R10496. BS R10497. BS R10498. BS R10499. BS R10500. BS R10501. BS R10502. BS R10503. BS R10504. BS R10505. BS R10506. BS R10507. BS R10508. BS R10509. BS R10556. BS R10557. BS R10558. BS R10559. BS R10560. BS R10561. BS R10562. BS R10563. BS R10564. BS R10565. BS R10566. BS R10567. BS R10568. BS R10569. BS R10570. BS R10571. BS R10572. BS R10573. BS R10574. BS R10575. BS R10576. BS R10577. BS R10578. BS R10579. BS R10580. BS R10581. BS R10582. BS R10583. BS R10584. BS R10585. BS R10586. BS R10587. BS R10588. BS R10589. BS R10590. BS R10591. BS R10592. BS R11933. BS R11934. BS R11935. BS R11936. BS R11937. BS R11938. BS R11939. BS R11940. BS R11941. BS R11942. BS R11943. BS R11944. BS R11945. BS R11946. BS R11947. BS R11948. BS R11949. BS R11950. BS R11951. BS R11952. BS R11953. BS R11954. BS R11955. BS R11956. BS R11957. BS R11958. BS R11959. BS R11960. BS R11961. BS R14311. BS R11115. BS R22320. BS R11183. BS R11154. BS R11155. BS R11156. BS R11157. BS R04252. XX DR TRANSPATH: MO000084523. DR EMBL: L41142; DR EMBL: U43185; DR UniProtKB: P42229; XX RN [1]; RE0016782. RX PUBMED: 10594041. RA Soldaini E., John S., Moro S., Bollenbacher J., Schindler U., Leonard W. J. RT DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites. RL Mol. Cell. Biol. 20:389-401 (2000). RN [2]; RE0019120. RX PUBMED: 7719937. RA HOU J., SCHINDLER U., HENZEL W.J., WONG S.C., MCKNIGHT S.L. RT Identification and purification of human Stat proteins activated in response to interleukin-2. RL Immunity 2:321-329 (1995). RN [3]; RE0023467. RX PUBMED: 9742102. RA Verdier F., Rabionet R., Gouilleux F., Beisenherz-Huss C., Varlet P., Muller O., Mayeux P., Lacombe C., Gisselbrecht S., Chretien S. RT A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B. RL Mol. Cell. Biol. 18:5852-5860 (1998). RN [4]; RE0024933. RX PUBMED: 14645506. RA Magne S., Caron S., Charon M., Rouyez M. C., Dusanter-Fourt I. RT STAT5 and Oct-1 form a stable complex that modulates cyclin D1 expression. RL Mol. Cell. Biol. 23:8934-8945 (2003). RN [5]; RE0049465. RX PUBMED: 16273093. RA Jones R. B., Gordus A., Krall J. A., MacBeath G. RT A quantitative protein interaction network for the ErbB receptors using protein microarrays. RL Nature 439:168-174 (2006). RN [6]; RE0051994. RX PUBMED: 11981045. RA Nevalainen M. T., Xie J., Bubendorf L., Wagner K. U., Rui H. RT Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium. RL Mol. Endocrinol. 16:1108-1124 (2002). RN [7]; RE0064848. RX PUBMED: 18071309. RA Tao W. J., Lin H., Sun T., Samanta A. K., Arlinghaus R. RT BCR-ABL oncogenic transformation of NIH 3T3 fibroblasts requires the IL-3 receptor. RL Oncogene 27:3194-3200 (2008). RN [8]; RE0065547. RX PUBMED: 18768389. RA Didichenko S. A., Spiegl N., Brunner T., Dahinden C. A. RT IL-3 induces a Pim1-dependent antiapoptotic pathway in primary human basophils. RL Blood 112:3949-3958 (2008). XX //